Review: taking Ciprofloxacin and Glipizide together


Summary

Drug interactions are reported among people who take Ciprofloxacin and Glipizide together. This review analyzes the effectiveness and drug interactions between Ciprofloxacin and Glipizide. It is created by eHealthMe based on reports of 200 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Ciprofloxacin and Glipizide >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ciprofloxacin

Ciprofloxacin has active ingredients of ciprofloxacin. It is often used in urinary tract infection. (latest outcomes from Ciprofloxacin 6,735 users)

Glipizide

Glipizide has active ingredients of glipizide. It is often used in diabetes. (latest outcomes from Glipizide 21,788 users)

On Jul, 20, 2016

200 people who take Ciprofloxacin, Glipizide are studied.


Number of reports submitted per year:

Ciprofloxacin and Glipizide drug interactions.

Drug effectiveness over time:

Ciprofloxacin:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Glipizide:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Ciprofloxacin:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 2 people)
Glipizide:
  • female: 100.0% - (2 of 2 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Ciprofloxacin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Glipizide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (2 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • hyperkalaemia
  • joint injury
  • pancreatitis
  • renal cell carcinoma
  • tendon rupture
  • disease progression
  • liver function test abnormal
  • renal failure acute
  • back pain
  • calculus urinary
1 - 6 months:
  • carbon dioxide decreased
  • chest pain
  • hypoglycaemia
  • pyrexia
  • renal failure acute
  • urinary tract infection
5 - 10 years:
  • acute psychosis
not specified:
  • fatigue
  • pain
  • nausea
  • renal failure acute
  • cardiac failure congestive
  • injury
  • anxiety
  • myocardial infarction
  • hypertension
  • diabetes mellitus

Most common drug interactions by gender *:

female:
  • diabetes mellitus
  • anxiety
  • nausea
  • chest pain
  • injury
  • pain
  • dyspnoea
  • cerebrovascular accident
  • fatigue
  • diabetic neuropathy
male:
  • renal failure acute
  • cardiac failure congestive
  • fatigue
  • cardio-respiratory arrest
  • pain
  • myocardial infarction
  • fall
  • multiple injuries
  • pleural effusion
  • pneumonia

Most common drug interactions by age *:

20-29:
  • diabetes mellitus
  • ketoacidosis
  • neuroleptic malignant syndrome
  • neuropathy peripheral
30-39:
  • chest pain
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • acute coronary syndrome
  • cardiac disorder
  • diabetic retinopathy
  • type 2 diabetes mellitus
  • cataract
  • cholecystitis acute
  • chronic obstructive pulmonary disease
40-49:
  • myocardial infarction
  • cardiac failure congestive
  • back pain
  • pleural effusion
  • type 2 diabetes mellitus
  • death
  • dehydration
  • foot ulcer
  • joint injury
  • nausea
50-59:
  • fatigue
  • renal failure acute
  • nausea
  • anxiety
  • cardiac failure congestive
  • multiple injuries
  • pain
  • cerebrovascular accident
  • myocardial infarction
  • acute respiratory distress syndrome
60+:
  • pain
  • renal failure acute
  • injury
  • cardio-respiratory arrest
  • fatigue
  • anxiety
  • pneumonia
  • dyspnoea
  • nausea
  • anhedonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ciprofloxacin and Glipizide?

Can you answer these questions?

More questions for: Ciprofloxacin, Glipizide

You may be interested in these reviews

More reviews for: Ciprofloxacin, Glipizide

On eHealthMe, Ciprofloxacin (ciprofloxacin) is often used to treat urinary tract infection. Glipizide (glipizide) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.